Wendy A. Keitel

Medicine · Health Sciences

37h-index19.6kcitations129works3.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Influenza Virus Research Studies(59), Respiratory viral infections research(40), Immune Response and Inflammation(22), SARS-CoV-2 and COVID-19 Research(19), Bacillus and Francisella bacterial research(14)

Publications121 total

A Phase 1 Double-Blinded Trial to Evaluate Safety, Immunogenicity, and Dosing of Measles-Vectored Chikungunya Virus Vaccine (MV-CHIK) in Healthy Adults
The Journal of Infectious Diseases·2025Open Access
Postnatal Zika and Dengue Infection and their Effects on Neurodevelopment Among Children Living in Rural Guatemala
The Pediatric Infectious Disease Journal·2024· 2 cited
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial
Clinical Infectious Diseases·2024· 3 citedOpen Access
A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults
Clinical Infectious Diseases·2024· 8 citedOpen Access
Postnatal Zika and Dengue Infection and Their Effects on Neurodevelopment Among Children Living in Rural Guatemala
SSRN Electronic Journal·2024Open Access
Delays in Hepatitis A vaccination in people with HIV in Houston, Texas between 2010 and 2018
Vaccine X·2023· 2 citedOpen Access
Delays in Hepatitis B Immunization Series Completion in People With Human Immunodeficiency Virus
Open Forum Infectious Diseases·2023· 4 citedOpen Access
Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
Nature Medicine·2023· 53 citedOpen Access
Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial
The Journal of Infectious Diseases·2023· 3 citedOpen Access
Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial
The Journal of Infectious Diseases·2023· 7 citedOpen Access
Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV-2 variants
npj Vaccines·2023· 29 citedOpen Access
A randomized, controlled Phase 1b trial of the Sm-TSP-2 Vaccine for intestinal schistosomiasis in healthy Brazilian adults living in an endemic area
PLoS neglected tropical diseases·2023· 26 citedOpen Access
Safety and immunogenicity of Multimeric-001 (M-001) followed by seasonal quadrivalent inactivated influenza vaccine in young adults – A randomized clinical trial
Vaccine·2023· 19 citedOpen Access
Safety and Immunogenicity of a monovalent inactivated influenza A/H5N8 virus vaccine given with and without AS03 or MF59 adjuvants in healthy adults
Clinical Infectious Diseases·2023· 15 citedOpen Access
Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial
The Lancet Infectious Diseases·2022· 25 citedOpen Access
Challenges and lessons learned from the rapid operationalization of a prospective cohort to study the natural history and neurodevelopmental outcomes of postnatal Zika virus infection among infants and children in rural Guatemala
PLoS neglected tropical diseases·2022· 5 citedOpen Access
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant
Cell Reports Medicine·2022· 166 citedOpen Access
Challenges and lessons learned from the rapid operationalization of a prospective cohort to study the natural history and neurodevelopmental outcomes of postnatal Zika virus infection among infants and children in rural Guatemala
2022· 3 citedOpen Access
Topical Imiquimod Does Not Provide an Adjuvant Effect When Administered With Inactivated Influenza A/H5N1 Vaccine in Healthy Young Adults
The Journal of Infectious Diseases·2021· 11 citedOpen Access
Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity Responses
The Journal of Infectious Diseases·2021· 20 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Robert L. Atmar(16), Kathryn M. Edwards(12), Shital M. Patel(11), Hana M. El Sahly(11), Robert B. Couch(8), Lisa A. Jackson(8), Heather Hill(8), Patricia Winokur(7), Thomas R. Cate(6), Mark J. Mulligan(6), Nadine Rouphael(6), Sharon E. Frey(6), Irene Graham(6), Diana L. Noah(6), David I. Bernstein(5), Robert Edelman(5), Rebecca C. Brady(5), Srilatha Edupuganti(5), Anna Wald(5), Joel I. Ward(4)